PICALM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.899800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.191600E-01
Normal-vs-Stage2
5.289000E-01
Normal-vs-Stage3
3.583200E-01
Normal-vs-Stage4
8.266600E-01
Stage1-vs-Stage2
5.521400E-01
Stage1-vs-Stage3
9.811800E-01
Stage1-vs-Stage4
5.218000E-01
Stage2-vs-Stage3
5.985600E-01
Stage2-vs-Stage4
6.524400E-01
Stage3-vs-Stage4
5.075600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.668800E-01
Normal-vs-AfricanAmerican
8.008000E-01
Normal-vs-Asian
2.633600E-01
Caucasian-vs-AfricanAmerican
5.286400E-01
Caucasian-vs-Asian
4.093200E-01
AfricanAmerican-vs-Asian
3.101600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.936200E-01
Normal-vs-Female
5.031000E-01
Male-vs-Female
7.263800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.559440E-01
Normal-vs-Age(41-60Yrs)
8.784600E-01
Normal-vs-Age(61-80Yrs)
3.932000E-01
Normal-vs-Age(81-100Yrs)
1.705840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.673900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.480200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.690390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.675100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.101840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.872800E-01
Normal-vs-Daily Drinker
3.332400E-01
Normal-vs-Weekly Drinker
2.391800E-01
Normal-vs-Occasional Drinker
5.928200E-01
Normal-vs-Social Drinker
3.999400E-01
Non Drinker-vs-Daily Drinker
8.708000E-01
Non Drinker-vs-Weekly Drinker
8.582800E-01
Non Drinker-vs-Occasional Drinker
2.577200E-01
Non Drinker-vs-Social Drinker
8.316000E-01
Daily Drinker-vs-Weekly Drinker
9.839000E-01
Daily Drinker-vs-Occasional Drinker
2.664800E-01
Daily Drinker-vs-Social Drinker
7.560200E-01
Weekly Drinker-vs-Occasional Drinker
2.496400E-01
Weekly Drinker-vs-Social Drinker
7.406800E-01
Occasional Drinker-vs-Social Drinker
4.594600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.662800E-01
Normal-vs-Grade 2
7.920900E-03
Normal-vs-Grade 3
1.565650E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.250100E-02
Grade 1-vs-Grade 3
3.532500E-02
Grade 1-vs-Grade 4
2.662800E-01
Grade 2-vs-Grade 3
9.202400E-01
Grade 2-vs-Grade 4
7.920900E-03
Grade 3-vs-Grade 4
1.565650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.253200E-01
Normal-vs-NonDiabetic
4.692800E-01
Diabetic-vs-NonDiabetic
4.244800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.301600E-01
Normal-vs-NoPancreatitis
4.042600E-01
Pancreatitis-vs-NoPancreatitis
4.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.509800E-01
Normal-vs-N1
5.405800E-01
N0-vs-N1
6.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.308600E-01
Normal-vs-TP53-NonMutant
6.164200E-02
TP53-Mutant-vs-TP53-NonMutant
2.774600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
